Mild cognitive impairment: animal models

Mild cognitive impairment (MCI) is an aspect of cognitive aging that is considered to be a transitional state between normal aging and the dementia into which it may convert. Appropriate animal models are necessary in order to understand the pathogenic mechanisms of MCI and develop drugs for its tre...

Full description

Bibliographic Details
Main Author: Pepeu, Giancarlo
Format: Online
Language:English
Published: Les Laboratoires Servier 2004
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181813/
id pubmed-3181813
recordtype oai_dc
spelling pubmed-31818132011-10-27 Mild cognitive impairment: animal models Pepeu, Giancarlo Basic Research Mild cognitive impairment (MCI) is an aspect of cognitive aging that is considered to be a transitional state between normal aging and the dementia into which it may convert. Appropriate animal models are necessary in order to understand the pathogenic mechanisms of MCI and develop drugs for its treatment. In this review, we identify the features that should characterize an animal model of MCI, namely old age, subtle memory impairment, mild neuropathological changes, and changes in the cholinergic system, and the age at which these features can be detected in laboratory animals. These features should occur in aging animals with normal motor activity and feeding behavior. The animal models may be middle-aged rats and mice, rats with brain ischemia, transgenic mice overexpressing amyloid precursor protein and presenilin 1 (tested at an early stage), or aging monkeys. Memory deficits can be detected by selecting appropriately difficult behavioral tasks, and the deficits can be associated with neuropathological alterations. The reviewed literature demonstrates that, under certain conditions, these animal species can be considered to be MCI models, and that cognitive impairment in these models responds to drug treatment. Les Laboratoires Servier 2004-12 /pmc/articles/PMC3181813/ /pubmed/22034045 Text en Copyright: © 2004 LLS http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
repository_type Open Access Journal
institution_category Foreign Institution
institution US National Center for Biotechnology Information
building NCBI PubMed
collection Online Access
language English
format Online
author Pepeu, Giancarlo
spellingShingle Pepeu, Giancarlo
Mild cognitive impairment: animal models
author_facet Pepeu, Giancarlo
author_sort Pepeu, Giancarlo
title Mild cognitive impairment: animal models
title_short Mild cognitive impairment: animal models
title_full Mild cognitive impairment: animal models
title_fullStr Mild cognitive impairment: animal models
title_full_unstemmed Mild cognitive impairment: animal models
title_sort mild cognitive impairment: animal models
description Mild cognitive impairment (MCI) is an aspect of cognitive aging that is considered to be a transitional state between normal aging and the dementia into which it may convert. Appropriate animal models are necessary in order to understand the pathogenic mechanisms of MCI and develop drugs for its treatment. In this review, we identify the features that should characterize an animal model of MCI, namely old age, subtle memory impairment, mild neuropathological changes, and changes in the cholinergic system, and the age at which these features can be detected in laboratory animals. These features should occur in aging animals with normal motor activity and feeding behavior. The animal models may be middle-aged rats and mice, rats with brain ischemia, transgenic mice overexpressing amyloid precursor protein and presenilin 1 (tested at an early stage), or aging monkeys. Memory deficits can be detected by selecting appropriately difficult behavioral tasks, and the deficits can be associated with neuropathological alterations. The reviewed literature demonstrates that, under certain conditions, these animal species can be considered to be MCI models, and that cognitive impairment in these models responds to drug treatment.
publisher Les Laboratoires Servier
publishDate 2004
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181813/
_version_ 1611477951207964672